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TAP assayWest Nile and dengue viruses are (re)emerging mosquito-borne ﬂaviviruses that cause signiﬁcant morbidity
and mortality in man. The identiﬁcation of mosquito proteins that associate with ﬂaviviruses may provide
novel targets to inhibit infection of the vector or block transmission to humans. Here, a tandem afﬁnity
puriﬁcation (TAP) assay was used to identify 18 mosquito proteins that interact with dengue and West Nile
capsid, envelope, NS2A or NS2B proteins. We further analyzed the interaction of mosquito cadherin with
dengue and West Nile virus envelope protein using co-immunoprecipitation and immunoﬂuorescence.
Blocking the function of select mosquito factors, including actin, myosin, PI3-kinase and myosin light chain
kinase, reduced both dengue and West Nile virus infection in mosquito cells. We show that the TAP method
may be used in insect cells to accurately identify ﬂaviviral–host protein interactions. Our data also provides
several targets for interrupting ﬂavivirus infection in mosquito vectors.eases, Department of Internal
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Dengue and West Nile viruses are members of the ﬂavivirus family,
which also includes yellow fever, Japanese encephalitis and tick-borne
encephalitis viruses. Flaviviruses are enveloped, single-stranded RNA
viruses that cause signiﬁcant human illness and mortality. Dengue is
among the most important human infectious diseases globally. There
are an estimated 100 million cases per year, with over 500,000 cases of
potentially fatal dengue hemorrhagic fever (Gubler, 2002; site, 2007).
WestNile virus can cause serious illness inman, resulting in encephalitis
and death, and is soon expected to be endemic in most of the United
States and South America (Mackenzie et al., 2004; Rappole et al., 2000).
There is no speciﬁc treatment for either West Nile or dengue virus, and
efforts to create an effective dengue vaccine have been hindered due to
safety concerns and potential antibody-dependent enhancement
(Gubler, 2002). Arboviruses exist in nature in cycles between an
arthropod vector and a vertebrate host. West Nile virus primarily
persists in mosquitoes and birds, with humans acting as “dead-end”
hosts who do not generally transmit virus (Mackenzie et al., 2004). The
cycle of dengue virus is unusual in that humans are the principalvertebrate hosts, therefore the virus can infect mosquitoes as they bite
an infectedhumanand the transmissionmaygoon to anewhumanhost
(Blair et al., 2000; Mackenzie et al., 2004).
The ﬂavivirus particle contains 3 structural proteins, the capsid (C),
envelope (E) and membrane (M) proteins. The structural proteins are
the only viral proteins found in viral particles, and the E protein is
thought to be the only protein exposed on the surface of the virion,
embedded in the lipid bilayer surrounding the capsid, membrane and
genetic material, and involved in virus entry into the cell (Kuhn et al.,
2002). The virion contains a positive-sense, single stranded RNA
genome that is translated into a single polyprotein. This polyprotein is
cotranslationally cleaved by host cell and viral proteases to produce the
individual viral proteins: the 3 structural proteins, C, E andM, and seven
non-structural (NS) proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B and
NS5 (Rice, 1996). The E protein is responsible for binding the host cell
receptor to allow virus entry into the cell as well as fusion with the host
cellmembrane to release the viral geneticmaterial (Brinton, 2002; Chen
et al., 1996). C is the only viral protein found within the lipid bilayer of
the mature virion and is known to complex with the viral RNA to form
the nucleocapsid (Mukhopadhyay et al., 2005). It has recently been
shown that the ﬂavivirus C protein can trigger cellular innate immune
signalingmechanisms during infection aswell as in the absence of virus
(Chen et al., 2009). The NS proteins perform various functions within
mammalian cells during infection. NS1 aids in replication and also has a
secreted form that may function in the extracellular ﬂuid. NS5 is the
RNA-dependentRNApolymeraseandNS3hasprotease activity andmay
also be involved in virus assembly. The NS3 protein forms a complex
with NS2B as a cofactor and contains a serine-protease activity domain
Fig. 1. Expression of TAP-tagged green ﬂuorescent protein (GFP) in mosquito cells.
NTAP-tagged GFP was expressed in C6/36 cells. Cells were (A) ﬁxed at 48 h and
analyzed by ﬂuorescence microscopy for GFP expression or (B) lysed and analyzed by
immunoblot for TAP-tagged GFP.
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viral polyprotein (Rice, 1996). The functions of NS2A, NS2B, NS4A and
NS4B proteins remained largely unknown until recent experiments
revealed anti-immune activity, including the inhibition of interferon
production, activity and signaling. NS2A inhibits interferon production
and signaling and NS4A to bind Jak-STAT and interferes with signaling
(Munoz-Jordan et al., 2003; Rice, 1996). A structural analysis ofﬂaviviral
NS4B has suggested functions in ER-stress response, altered gene
expression and replication efﬁcacy (Welsch et al., 2007). Since viruses
contain a very limited number of proteins, it is likely that each viral
protein interacts with several cellular proteins to enhance the
environment for infection and decrease the ability of the cell to inhibit
virus infection and production.
In the past decade, there has been an expansion in research focused
on changes in mosquito gene expression due to pathogen infection.
Much of this research has focused on the responses of Anopheles
mosquitoes tomalaria infection and recent reports illustrate that several
host factors are required, and beneﬁcial, for the malarial life cycle in
mosquitoes (Ghosh et al., 2001; Xu et al., 2005). There have also been
reports on Aedes gene expression during ﬂaviviral infection with
an emphasis on innate immune genes (Sim and Dimopoulos, 2010;
Souza-Neto et al., 2009; Xi et al., 2008). Fluorescent differential display
has also been used to identify genes in the midgut of Culexmosquitoes
with altered expression upon infection with West Nile virus (Smartt
et al., 2009). Since these studies focus on the levels of mosquito gene
transcripts, they may miss host factors that are important for infection
but do not have altered transcription levels. In addition, these assays do
not provide any information regarding the protein interactions that
occur during pathogen gene expression in the mosquito. Uncovering
these interactions is crucial to developing a complete picture of the
relationship of infectious agents with their transmission vectors.
Several methods commonly used to identify protein interactions
include the yeast two-hybrid method, cotranslocation and co-
immunoprecipitation (Honda et al., 2007; Hui et al., 2006). Though
relatively successful, thesemethods cannot provide a comprehensive list
of interacting proteins in live cells. In addition, none of these methods
can be easily adapted for use with mosquito cells due to the lack of
readily available arthropod reagents and antibodies. The tandem afﬁnity
puriﬁcation (TAP) assay is an accurate and reliable way to explore
protein interactions occurring naturally in live cells. The TAP method
enables the puriﬁcation of interacting protein complexes under near-to-
physiological conditions and has been successfully used to identify a
number of mammalian cellular proteins that bind viral proteins,
including the inﬂuenza RNA polymerase, human papillomavirus E1
helicase and the Epstein–Barr virus nuclear antigen 5 (Cote-Martin et al.,
2008; Forsman et al., 2008; Jorba et al., 2008).We applied the TAP assay,
followed by mass spectrometry, to characterize mosquito components
that bind to West Nile and dengue viral proteins. We chose to express
NS2A and NS4B nonstructural proteins to search for mosquito proteins
that may be involved in the immune response to viral infection, as they
are known to interact with components of the mammalian immune
system during infection (Liu et al., 2004; Munoz-Jordan et al., 2005). In
addition, we chose to look for mosquito binding partners of E and C, as
they are thedominantproteins found in thematureﬂavivirion.We show
that the TAP method can be used to identify viral–host protein
interactions in insect cells. Identiﬁcation of insect factors important for
arboviral infection may lead to novel ways to break the human–vector
transmission cycle.
Results
Expression of tagged ﬂaviviral proteins in mosquito cells
A tandem afﬁnity puriﬁcation (TAP) assay along with mass
spectrometry was used to identify mosquito proteins that interact
with ﬂaviviral proteins. First, the activity of the nTAP plasmid promoterin mosquito cells and level of expression of the tagged viral proteins
were assessed to conﬁrm that the TAP assay would function in these
insect cells. The green ﬂuorescent protein (GFP) gene was ampliﬁed
using the polymerase chain reaction (PCR) and cloned into the nTAP
vector. This new plasmid, nTAP–GFP, was transfected into C6/36
mosquito cells and showed a high level of GFP expression by
immunoblot and immunoﬂuorescence (Fig. 1). The genes for 2
structural (envelope and capsid) and 2 nonstructural proteins (NS2A,
NS4B) from both West Nile and dengue viruses were cloned into the
nTAP vector as fusion proteins with the streptavidin-binding protein
(SBP) and calmodulin-binding protein (CBP) tags (Fig. 2A). These
plasmids were transfected into C6/36 cells and expression levels were
examined at 48 h. C6/36 cells are derived from the Aedes albopictus
mosquito, which is a secondary vector for dengue infection worldwide,
and these cells are highly susceptible to bothdengueandWestNile virus
infection in the laboratory. Immunoblots of the cell lysates, using an
antibody against the CBP tag, revealed bands of the appropriate size for
all 8 viral proteins (Fig. 2B). Immunoﬂuorescence analysis conﬁrmed
that all of theproteinswere expressed in transfectedmosquito cells. The
West Nile and dengue virus NS2A,NS4B and envelopeproteins localized
to the cytoplasm, and the capsid proteins were detected in the nucleus
(Fig. 2C), consistent with reported data regarding ﬂaviviral protein
localization (Bulich and Aaskov, 1992; Mackenzie et al., 1998; Miller et
al., 2006; Senigl et al., 2004). These data suggest that tagged ﬂaviviral
fusion proteins may be used in mosquito cells to identify interacting
arthropod proteins.
Identiﬁcation of mosquito proteins that interact with West Nile and
dengue virus NS2A, NS4B, capsid and envelope proteins
The nTAP-viral gene plasmids (Fig. 2A) were transfected into C6/36
cells and the TAP assay performed on cell lysates to isolate tagged viral
proteins along with interacting mosquito proteins. The nTAP–GFP
plasmid and the empty nTAP plasmid served as controls. The ﬁnal
solution eluted from the calmodulin resin was subjected to LC/MS–MS
for peptide sequencing and identiﬁcation. The tags and viral proteins
were correctly detected in the appropriate cell lysates and any proteins
Fig. 2. Expression of TAP-tagged viral proteins. A. Schematic of the TAP plasmids used to express viral proteins fused to streptavidin-binding protein (SBP) and calmodulin binding
protein (CBP). Arrow represents the cytomegalovirus promoter (CMV). B. Immunoblot analysis of viral proteins. Tagged proteins were expressed in C6/36 cells, cells were lysed and
analyzed by immunoblot with an antibody against CBP. Lanes 1–8: 1. dengue NS2A, 2. dengue NS4B, 3. dengue capsid, 4. dengue envelope, 5. WNV NS2A, 6. WNV NS4B, 7. WNV
capsid,and 8. WNV envelope. C. Immunoﬂuorescence analysis. Tagged proteins were expressed in C6/36 cells and analyzed by ﬂuorescence microscopy using an antibody against
CBP. Left panel: viral protein expression (red); right panel: location of the nucleus in the cell with DAPI stain (blue).
Table 1
Mosquito proteins identiﬁed as binding partners of select ﬂaviviral proteins.
Flaviviral protein Mosquito protein A. aegypti protein ID
Dengue capsid Myosin heavy chain gi|157118639
Enolase gi|157121051
Histone 2A gi|157141861
Histone 4 gi|108880599
Histone 2B gi|157138408
Actin gi|677901
West Nile capsid Histone 3 gi|157138412
Histone 2B gi|157138408
Kinectin gi|157137337
Actin gi|677901
Dengue envelope Myosin heavy chain gi|157118639
Myosin light chain gi|108876629
Cadherin gi|108883460
Dystroglycan-like protein gi|108870400
Laminin alpha-1, 2 chain gi|108883156
West Nile envelope Myosin heavy chain gi|157118639
Myosin light chain gi|108876629
Enolase gi|157121051
PI3 kinase gi|157132541
Beta tubulin gi|108881720
Dengue NS2A Elongation factor 1-alpha gi|56684617
40S ribosomal protein S6 gi|193806324
60S ribosomal protein L4 gi|157124831
Myelinprotein expression factor gi|157137653
West Nile NS2A Myosin heavy chain gi|157118639
40S ribosomal protein S6 gi|193806324
Beta tubulin gi|108881720
Dengue NS4B Elongation factor 1-alpha gi|56684617
Myosin light chain gi|108876629
Actin gi|677901
West Nile NS4B Elongation factor 1-alpha gi|56684617
Actin gi|677901
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background and eliminated from further study. Mosquito genes were
identiﬁed using sequence alignment of the identiﬁed peptides with the
recently publishedAedes aegypti genome(Neneet al., 2007). A total of 18
mosquito proteins were identiﬁed as potential interacting partners of
the 8 ﬂaviviral antigens. Themosquito proteins were identiﬁed by using
the (Table 1). Capsid proteins bound histones, consistent with the
localization of capsid to thenucleus (Fig. 2B). The viral envelope proteins
bound several cell-surface proteins, including cadherin, laminin alpha-1
and dystroglycan-like protein, suggesting that these proteins could be
possible viral receptor molecules. The NS proteins bound multiple
translation factors, such as elongation factor 1-alphaand the40Sand60S
ribosomal proteins: consistent with the localization of these proteins to
the cytoplasm (Fig. 2B) and reports of ﬂaviviral NS protein involvement
in RNA replication and translation (Khromykh et al., 2000; Umareddy et
al., 2006). Some of the ﬂaviviral proteins also bound one or more
mosquito proteins involved in the cytoskeleton and cellular trafﬁcking,
such as actin, myosin and beta-tubulin.
Analysis of the interaction between West Nile and dengue virus envelope
proteins and a mosquito cadherin homolog
The TAP assay identiﬁed 18mosquito proteins as binding partners of
West Nile and dengue virus proteins. We decided to focus on the
interaction between mosquito cadherin and the ﬂaviviral envelope
proteins for further analysis. Cadherin is a glycoprotein often found on
the surface of cells and could be a receptor for dengue orWest Nile virus
in mosquitoes, as the envelope protein is thought to bind the cellular
receptor during virus entry into a host cell. A BLAST search for cadherin
against the A. aegypti genome (Nene et al., 2007) using the mosquito
Fig. 3.Mosquito cadherin precipitates and colocalizes with dengue and West Nile virus envelope protein. C6/36 cells were cotransfected with an HA-tagged mosquito cadherin and
tagged viral envelope gene expression plasmids. A, B. At 48 h, cells were lysed and cadherin was precipitated using an antibody to the HA-tag. Immunoblot analysis was done using
antibodies to virus envelope (top panel) and the HA-tag antibody (bottom panel. IBs are shown for coimmunoprecipitation with HA-tagged mosquito cadherin and tagged ﬂaviviral
envelope proteins (A. dengue virus; B. West Nile virus).). IB, immunoblot;−, absence of; +, presence of; env, envelope protein. C. Graph of ELISAmeasuring levels of dengue orWest
Nile virus that bound GST-tagged cadherin or EF1α, normalized to levels that bound GST alone. D. C6/36 cells were again cotransfected with an HA-tagged mosquito cadherin and
tagged viral envelope gene expression plasmids. At 48 h, cells were ﬁxed and stained with antibodies to virus envelope (top panel—dengue virus, bottom panel—West Nile virus) and
the HA-tag antibody. Cells were analyzed by ﬂuorescence microscopy and representative images are shown. DAPI stain was used to visualize the nucleus. White circles highlight
areas of colocalization between cadherin and viral envelope proteins.
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30.8% identity and 58.1% similarity to human E-cadherin, a mammalian
ligand important for cell adhesion (van Roy and Berx, 2008). The
extracellular calcium-binding domains were conserved (Handschuh et
al., 2001), suggesting that this is a functional membrane adhesion
cadherin protein. To test this, an HA-tagged gene encoding mosquito
cadherinwas cloned into thepAc5.1/V5-HisA insect expressionplasmid.
Mosquito cells were transiently transfectedwith ﬂaviviral envelope and
HA-cadherin plasmids. A co-immunoprecipitation assay using an HA-
antibody to capture HA-cadherin was done with the cell lysates and
revealed West Nile and dengue envelope proteins in the precipitate
along with cadherin (Figs. 3A and B). The experiment was repeated
using empty TAP vector as a control and we did not see any co-
immunoprecipitation between the TAP tags and HA-tagged mosquito
cadherin. An ELISA assaywas donewith inactivated virions and puriﬁed
GST-tagged mosquito cadherin to conﬁrm functional interaction
between cadherin and viral envelope proteins. Puriﬁed GST alone and
GST-tagged EF1α were used as controls. As shown in Fig. 3C, both
dengue and West Nile viruses bound to mosquito cadherin but not to
puriﬁed EF1α protein. To visualizewhere the proteins interacted during
expression in the cell, HA-cadherin and the tagged viral proteins were
again co-transfected into mosquito cells. The cells were ﬁxed and
stained with an antibody against HA and antibodies against viral
envelope proteins, and analyzed by microscopy. Both envelope and
cadherin proteins were found in the cytoplasm and were colocalized in
distinct foci near the plasma membrane (Fig. 3C). Some cadherin was
also found near or along the plasmamembrane and nuclearmembrane,representative of themany functions of the protein in the cell (Yap et al.,
2007). To illustrate that the interaction between the envelope and
mosquito cadherinproteinwas speciﬁc, a separate immunoﬂuorescence
experiment was done using HA-tagged elongation factor 1-alpha
(EF1α). Thismosquito proteinwas found to bindnonstructural proteins
NS2A and NS4B in the TAP assay but was not found to interact with the
envelope protein of either dengue or West Nile virus. The tagged viral
proteinswere again transfected intomosquito cells alongwithHA-EF1α
and cells were ﬁxed and stained as before. Protein expression was
visualized using ﬂuorescent microscopy and no colocalizationwas seen
between either envelope protein and mosquito EF1α (Fig. S1).Expression of identiﬁed mosquito genes is altered during West Nile and
dengue virus infection
In order to further analyze the role the identiﬁed mosquito proteins
may play in West Nile and dengue infection, the levels of gene
expressionwere determined after viral infection ofmosquito cells. At 24
post-infection, cells were lysed, RNAwas isolated and cDNA was made.
Expression was quantiﬁed using QPCR and normalized to mosquito
actin. All of the genes had increased expression upon West Nile
infection, with the exception of H2A, which was slightly decreased
(Fig. 4). Dengue infection resulted in increased gene expression for all
proteins except H3 and laminin. Myosin light and heavy chains,
ribosomal proteins 40S S6 and 60S L4 and cadherin had over 3-fold
increased expression during infection with both viruses. West Nile
Fig. 4. Expression of interactingmosquito proteins is altered during dengue andWest Nile infection. C6/36 cells were infected with dengue orWest Nile virus (MOI 0.1). At 48 h post-
infection, RNA was extracted from the cells and cDNA was made. Quantitative real-time PCR (qRTPCR) was done on the cDNA for the mosquito genes identiﬁed in the TAP assay.
Values were normalized to mosquito actin expression and experiments were done in triplicate. Mean values are shown +/− standard deviation. pb0.005 for all values when
compared to gene expression levels in uninfected cells.
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expression in themosquito cell, with over 6-fold increase in expression.
A beneﬁcial role for the interacting mosquito proteins in West Nile and
dengue virus infection: inhibition of identiﬁed proteins inhibits virus
infection
The viral proteins may have bound the mosquito proteins because
they are required for infection. If so, then blocking themosquito proteins
should reduce dengue and/or West Nile virus infection. To conﬁrm that
the mosquito proteins were necessary for virus infection, chemical
inhibition was used to reduce the inﬂuence of selected mosquito
proteins, where reagents were available. Five chemical inhibitors were
used, cytochalasin D (which blocks actin polymerization), latrunculin A
(which reduces the amount of F-actin), 2,3-butandione-2-monoxime
(2,3-BDM: which inhibits myosin), LY294 (which inhibits PI3-kinase)
and ML7 (which inhibits myosin light chain kinase). The drug
concentrations were chosen based on amounts previously used in the
literature and, at the concentrations used, none of the inhibitors had any
signiﬁcant effect on cell viability or cell number before virus was added.Fig. 5. Inhibition of viral infection with chemical knockdown of mosquito proteins. Chemica
Cells were incubated at room temperature for 1 h and then infected with dengue orWest Nile
made. QPCR was done for viral envelope protein on the cDNA and values were normalize
triplicate. Mean values are shown +/− standard deviation. Cyto D = cytochalasin D, LatA—
concentration of each chemical inhibitor used. p Valueb0.005 for each inhibitor at the IC50Using the trypanblue exclusion test,we found that over 90%of cellswere
viable at the highest concentration of drug used for all ﬁve chemical
inhibitors, whichwas comparable to cells grown inmedia alone. All ﬁve
inhibitors reduced both dengue andWest Nile virus infection in a dose-
dependent manner (Fig. 5). ML7 had a much greater impact on dengue
virus than West Nile virus. In contrast, both cytochalasin D and
latrunculin A reduced West Nile virus infection to a larger degree than
denguevirus.Wesawthe following IC50s forWestNile anddenguevirus
infection, respectively: cytochalasin D— 6 and 2 μg/mL, ML7— N50 and
47 μM, LY294 — both N15 over 50 μM, 2,3-BDM — both N50 mM and
latrunculin A — 4.8 and 5.2 nM.
Discussion
There has been a recent increase in research focused on the effects
of ﬂaviviral infection on mosquito protein expression. Sessions et al.
showed that a number of genes have altered expression upon dengue
infection of Drosophila cells, including several that encode proteins
involved in endocytosis, RNA-binding and the unfolded protein
response. They further demonstrated that many of these proteinsl inhibitors were added to 24-well plates of C6/36 cells at the concentrations indicated.
virus (MOI 0.1). At 24 h post-infection, RNAwas extracted from the cells and cDNAwas
d to mosquito actin expression in each well. Each inhibitor experiment was done in
latrunculinA. Cell viability was N85% using trypan blue exclusion test at the maximum
concentration versus media alone using one-way ANOVA and Bonferroni post-test.
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mammalian cells (Sessions et al., 2009). Another study investigating
the protein proﬁle of dengue-infected Aedesmosquitoes found several
proteins in infected mosquitoes that were not present in uninfected
mosquitoes, though the proteins were identiﬁed by size only (Rohani
et al., 2005). Though these assays provide valuable information about
the alteration of mosquito transcripts in response to ﬂavivirus
infection, they do not provide information about protein interactions
at the cellular level during infection. This study examined the
interactions betweenmosquito cell proteins and the envelope, capsid,
NS2A and NS4B viral proteins of West Nile and dengue viruses using
the TAP assay. This is the ﬁrst reported use of the TAP assay to identify
interacting host cell partners of ﬂaviviral proteins as well as the ﬁrst
time this method has been used in insect cells. Many pathogens use
insects as transmission vectors and this assay presents an efﬁcient
way to identify insect binding partners of pathogen antigens under
native cellular conditions.
We identiﬁed 18mosquito proteins as binding partners ofWest Nile
and dengueproteins. The normal cellular functions of the identiﬁed host
proteins varied greatly within the set, yet the class of host proteins that
each individual ﬂaviviral protein bound was remarkably constant. The
nonstructural proteins of both West Nile and dengue viruses bound
multiple host cell translation factors, such as elongation factor 1-alpha
(EF1-alpha) and 40S and 60S ribosomal proteins, which corresponds
with reports in the literature of ﬂaviviral nonstructural protein
involvement in viral RNA replication and translation (Khromykh et al.,
2000). Threeﬂaviviral proteins, dengueNS2A anddengue andWestNile
NS4B, bound to mosquito EF1-alpha. Recent research has shown that
EF1-alpha binds ﬂaviviral RNA, presumably to aid in viral replication
(Blackwell and Brinton, 1997). This is the ﬁrst report of EF1-alpha
having a direct interaction with a ﬂaviviral protein and the reasons for
the binding could be to aid in viral replication or translation or to impair
normal cellular processes. The NS2A proteins of both dengue andWest
Nile viruseswere found to bind 40S and 60S ribosomal proteins and this
interaction is likely linked to ﬂaviviral RNA translation. There have been
several reports of viral RNA interactions with ribosomal proteins,
including Epstein–Barr virus noncoding RNA EBER1, which recruits
ribosomal L22 during infection, presumably to aid in viral replication
(Fok et al., 2006). In addition, the hepatitis C (HCV) IRES region
associates with ribosomal S5 and it was suggested that this interaction
functions to position HCV RNA on the 40S ribosomal subunit during
translation (Fukushi et al., 2001). This is the ﬁrst report of a ﬂaviviral
protein binding either 40S or 60S ribosomal protein. If these translation
factors are requiredduring theprocessingof the viral genomeor for viral
replication, the ﬂaviviral proteins may have evolved mechanisms to
bind and localize the proteins in an appropriate area of the cell.
Both dengue and West Nile virus envelope proteins bound several
mosquito cell-surface proteins, which may be putative virus receptors.
We found that laminin bound to the dengue envelope protein, and
several laminin binding proteins and receptors have already been
suggested to act as receptors or cofactors for both dengue andWest Nile
virus entry in mosquito and mammalian cells (Bogachek et al., 2008;
Sakoonwatanyoo et al., 2006). This indicates that the TAP method can
accurately identify host proteins known to bind components of the
virion surface by using the envelope protein. As our assay analyzed
protein interactions within the cell, not on the cell surface, the viral
envelope could be binding receptor proteins to prevent localization to
the plasmamembrane. Viruses have been shown to bind their receptors
intracellularly to prevent protein from reaching the cell surface, thus
inhibiting further virus entry. A good example of this is the down-
regulation of CD4, the HIV-1 receptor, during infection of a T cell with
HIV-1 (Clapham and McKnight, 2002). In addition to laminin, the
dengue envelope bound a mosquito homolog of cadherin as well as a
dystroglycan-like protein, which are both glycoproteins thought to be
expressed on the cell-surface. Alpha-dystroglycan is known to be the
receptor for the arenaviruses lymphocytic choriomeningitis virus andLassa virus in mammalian cells (Cao et al., 1998). Cadherin is known to
be expressed on the surface of mammalian cells (van Roy and Berx,
2008) and the mosquito homolog could be a putative receptor or co-
factor for both dengue and West Nile viruses. In endothelial cells,
vascular endothelial cadherin is downregulated in association with
increased cellular permeability due to dengue virus infection (Dewi et
al., 2008). We chose to focus on the interaction between the ﬂaviviral
envelope protein and the mosquito cadherin for further analysis. The
interaction between the two proteinswas conﬁrmed using immunoblot
analysis. The cadherin binding was speciﬁc and signiﬁcant for both
dengue and West Nile virus envelope proteins. In addition, immuno-
ﬂuorescence analysis provided evidence that the twoproteins colocalize
when co-expressed in the mosquito cell. It remains to be seen whether
the mosquito cadherin protein can act as a ﬂaviviral receptor during
infection, yet both the speciﬁc binding of the envelope protein to
cadherin and the colocalization of the proteins within the cell suggest
this possibility. The West Nile virus envelope protein was also found to
bind mosquito PI3-kinase in our assay and the PI3-kinase signaling
pathway is known to be activated during ﬂavivirus infection to inhibit
apoptosis. Blocking PI3-kinase using the chemical inhibitor LY294
reduced both West Nile and dengue infection in mosquito cells in a
dose-dependent manner, suggesting that the protein may play a role in
the viral life cycle.
Most of the ﬂaviviral proteins investigated here also bound one or
more proteins involved in the cytoskeleton andwith cellular trafﬁcking,
suchas actin,myosin andbeta tubulin.Viral proteinsmaybeexpected to
bind these proteins, as viruses must rely on host cellular factors for the
trafﬁcking of their own proteins and components in the cell. Both
structural and non-structural proteins bound myosin light and heavy
chains, suggesting an important role for myosin in the ﬂaviviral life
cycle. Additionally, blockingmyosin andmyosin light chain kinase with
two chemical inhibitors, 2,3-BDM and ML-7, signiﬁcantly reduced both
dengue and West Nile virus infection in mosquito cells. Mammalian
myosin Vc protein has been shown to be involved in the release of
dengue from liver cells (Xu et al., 2009), and the mosquito myosin is
likely playing a role in viral trafﬁcking, either during entry or assembly
and release of virus. West Nile virus NS2A and envelope protein both
bound beta-tubulin, which are building blocks of microtubules and an
important component of the cytoskeleton. Japanese encephalitis virus
NS3 protein has been shown to associatewith tubulin andmicrotubules
during virus replication (Chiou et al., 2003). Another group reported
that a tubulin-like protein in C6/36 cells binds dengue 2 virus,
presumably through the envelope protein on the virus surface (Chee
and AbuBakar, 2004), suggesting that tubulin could be acting as a
receptor or cofactor for entry. In addition, tubulin is known to bind
enolase, another protein found to bind West Nile virus envelope and
dengue capsid proteins in our assay. Enolase has been shown to be
required for Sendai virus transcription via its interaction with tubulin
(Ogino et al., 2001) and there may be a similar requirement for the two
proteins in ﬂavivirus infection. HCV replication complexes (RCs) are
known to associate with microtubules and HCV NS3 and NS5A interact
with tubulin and actin during replication. It is thought that HCV RCs
move along microtubules to travel within the cell (Lai et al., 2008) and
this method may be utilized by dengue and West Nile ﬂaviviruses.
Mosquito actin bound both structural and nonstructural proteins from
West Nile and dengue viruses. Actin has been indicated in various roles
in the life cycles of several viruses, including replication of inﬂuenza A
(Arcangeletti et al., 2008), the assembly of HIV-1 (Jolly et al., 2007) and
the release of vaccinia (Arakawa et al., 2007). The inhibition of actin
polymerization inmosquito cells using latrunculin-A and cytochalasinD
lowered the infection of the cells with both dengue and West Nile
viruses, though it had a greater impact on West Nile infection. Actin is
likely involved in several aspects of the viral life cycle and it is clear that
both dengue andWest Nile have at least a partial requirement for actin
polymerization during infection. Since blocking the function of these
mosquito proteins decreased infectionwith both viruses, they are likely
185T.M. Colpitts et al. / Virology 417 (2011) 179–187beneﬁcial and/or necessary for infection. Future studies may include an
investigation into these interactionsusingRNAi in cells derived from the
A. aegyptimosquito, as C6/36 cells are known to be dysfunctional in the
RNAi response, (Brackney et al., 2010).
Conclusions
This study identiﬁedmosquito binding partners of ﬂaviviral proteins
that may play important roles as host factors during viral infection of
mosquito cells. This list provides a useful starting point for the ﬁeld of
ﬂaviviral pathogenesis in the mosquito and present targets for further
investigation of the mosquito–ﬂaviviral relationship. We identiﬁed and
conﬁrmed binding between viral proteins and mosquito cadherin. We
also conﬁrmed the importance of actin, myosin, PI3-kinase and myosin
light chain kinase in West Nile and dengue infection of mosquito cells.
Exploration of the interactions between West Nile and dengue viral
proteins with the proteins of the mosquito transmission vector is
necessary, in hopes of identifying proteins vital to the viral life cycle and
perhaps novel candidates that will help break the human–vector
infection cycle.
Materials and methods
Cell lines and cultivation
C6/36 Aedes albopictus cells (ATCC, VA) were used for all
transfection and infection studies. The cells were grown at 29 °C in
DMEM supplemented with 10% heat-inactivated fetal bovine serum
(Gemini, CA), 1% penicillin–streptomycin and 1% tryptose phosphate
broth (Sigma, MO).
TAP expression plasmid constructs
All plasmids were prepared using Qiagen miniprep kits (Valencia,
CA) after standard transformation into DH5α competent bacterial cells.
The tagged virus protein nTAP expression plasmids were made by
cloning the coding regions for each viral protein into theN-terminal TAP
plasmid (Stratagene, CA). Oligos can be found in Table S1.
Transfection of plasmids
All plasmids were transfected into C6/36 mosquito cells using
Effectene (Qiagen, CA) according tomanufacturer's instructions. Brieﬂy,
for a 10-cm2 plate, 10 μg of DNA was mixed with 500 μL buffer EC and
32 μL enhancerwas added. Thiswas allowed to incubate for 5 min at RT.
Then 30 μL Effectene reagent was added and the solution vortexed
brieﬂy. After a 10 min incubation, the solution was added to the cells.
Expressionwas observed after 24 h and peaked at 48 h, as measured by
levels of GFP expression.
TAP assay
The TAP assay was used to identify mosquito cell proteins that
interactedwithﬂaviviral proteins after expression in C6/36 cells. Brieﬂy,
at 48 hpost-transfection, cellswerewashedwith PBS(-) and lysedusing
1X lysis buffer containingprotease inhibitors. All stepswere done at 4 °C
to maintain the protein interactions. The cell lysates were applied to
streptavidin resin, incubated at 4 °C for 2 h,washed, and boundproteins
eluted off. A second puriﬁcation step was done with calmodulin resin
and the proteins were boiled off into PBS(-). The eluted proteins were
analyzed at the Yale UniversityW.M. Keck Foundation core facility. The
eluatewas subjected to trypsin digestion followed by LC/MS–MS(liquid
chromatography and mass spectometry) for peptide sequencing and
identiﬁcation using the recently completed A. aegyptimosquito genome
(Nene et al., 2007). Putative mosquito proteins were identiﬁed via
amino acid sequence identity to both known mosquito proteins andtheir mammalian counterparts using the BLAST software on the NCBI
website. Mosquito proteins found to bind the tags alone as well as
proteins found to bind tagged green ﬂuorescent protein were
eliminated as putative interacting partners.
Expression of mosquito proteins
Mosquito genes were identiﬁed using sequence alignment of
identiﬁed peptides with the recently published A. aegypti genome
(Nene et al., 2007). RNA was isolated from mosquito cells using
RNeasy (Qiagen, CA) according tomanufacturer's instructions and cDNA
made by reverse transcription with a Superscript kit (Invitrogen, CA)
according to the manufacturer's instructions. For expression in insect
cells, mosquito genes were ampliﬁed from the cDNA, fused to GFP and
cloned into an insect expressionvectorpAc5.1/V5-HisA (Invitrogen, CA).
Protein production
The protein coding sequences were cloned into the pGEX-6P-2
plasmid and transformed into BL-21-Gold (DE3) competent cells
(Stratagene, CA) using a standard transformation protocol. The
bacteria was grown in LB media overnight at 37 °C, diluted in fresh
media and grown to mid-log phase (A600=0.7). The expression of
GST-tagged protein was induced by adding isopropyl-beta D-thioga-
lactoside (IPTG) to 0.1 mM ﬁnal concentration and allowed to grow
for 4 h at 37 °C. The cells were lysed, Triton X-100 was added to a ﬁnal
concentration of 1% and cells were shaken at 25 °C for 30 min to
solubilize proteins. The crude extract was centrifuged at 10,000×g for
5 min at 4 °C and the supernatant was incubated with glutathione
sepharose (GS) 4B (GE, NJ) for 30 min at 25 °C. The GST-tagged
proteins were eluted by adding elution buffer (50 mM Tris–HCl,
10 mM reduced glutathione, pH8.0), incubating at 25 °C for 10 min
and centrifugation at 500×g for 5 min.
ELISA analysis
5 μg of GST or GST-tagged mosquito protein was coated onto a 96-
well ELISA plate (Thermo Fisher Sci, MA) and incubated overnight at
4 °C. The plate was blocked with 1% BSA in PBS(-) and incubated with
inactivated virus for an hour at RT. The proteins were washed off,
antibodies were added for 30 min at RT, washed off and secondary-
HRP was added for 30 min at RT, washed off and TMB substrate was
added for 20 min at RT. Stop solution was added and the O.D. of the
wells was read at 450 nm.
Flavivirus infection
C6/36 cells at 75% conﬂuence were infected with dengue 2 New
Guinea C or West Nile NY99 virus (generous gifts of Dr. John
Anderson, Connecticut Agricultural Experiment Station, CT) at an MOI
of 0.1 or 1.0, as indicated in the ﬁgure legends. Virus was added
directly to media, washed off after 4 h when new media was added
and cells were left for 24 h, at which point the various assays were
conducted. Viral stocks were propagated in C6/36 cells for 7 days
before supernatant was centrifuged, virus collected and stored at
−80 °C.
Use of chemical inhibitors
All chemicals were purchased from Sigma (MO). Cytochalasin D
was provided as a 5 mg/mL stock in DMSO, latrunculin A was made as
a 25 mg/mL stock in DMSO, 2,3-butanedione monoxime (2,3-BDM)
was made as a 100 mg/mL stock in methanol, LY294 was made as a
5 mg/mL stock in DMSO and ML-7 was dissolved in ethanol:water
(1:1). All were diluted in DMEM immediately before use. C6/36 cells
were incubated with each inhibitor for 1 h at room temperature and
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sure to keep the same ﬁnal concentration of drug in the media
throughout the infection process. At 24 h, cells were lysed, RNA was
isolated using the RNEasy kit (Ambion, TX) and cDNAwas made using
the Superscript kit (Invitrogen, CA). This cDNA was used in a
quantitative RT-PCR reaction to determine copy number of viral
envelope gene using the following oligos and a standard plasmid with
known gene copy number:
Dengue 5′-caggctgaggatggacaaactac-3′ & 5′-caaaagggatcttacatgga-
gaac-3′
West Nile 5′-ctactgtggagtcgcacgg-3′ & 5′-cctctccatattctccaagc-3′
Cell viability assay
The cells were incubated in chemical inhibitors as described above
and then assayed for viability using 0.4% trypan blue solution (Sigma,
MO) in a 1:1 ratio with a cell solution in PBS(-). The cells were
analyzed by microscopy and percentage of viable cells was calculated.
qRTPCR
Expression levels of mosquito genes as well as viral envelope
proteins were quantiﬁed via a qRT-PCR reaction using mosquito cell
cDNA. The qRT-PCR reaction was done with SYBR green mix (Biorad,
CA) in an iCycler machine (Biorad, CA). All assays were done in
triplicate using cDNA made from one RNA isolation. The reaction
conditions were as follows: 95 °C for 5 min. followed by 50 cycles of
20 s at 95 °C, 20 s at 56 °C, 8 s at 72 °C, and a ﬁnal extension step of
5 min at 72 °C. Gene expression changes were calculated based on
changing Ct value normalized to actin expression. Oligos can be found
in Table S2.
Western blots
The plasmids containing the gene for desired protein expression
were transfected into C6/36 cells and at 48 h the cells were lysed. The
lysate was boiled in SDS–PAGE buffer with 2% beta-mercaptoethanol,
run on a 12% SDS–PAGE gel and the proteins were then transferred
to nitrocellulose. The nitrocellulose was blocked with 5% milk in 1%
TBST for 1 h at RT and then incubated with the appropriate primary
antibody overnight at 4 °C. The nitrocellulose was washed and then
incubated with a horseradish peroxidase secondary antibody for 1 h
at RT and then washed again. The protein blots were incubated with
ECL substrates (Amersham, NJ) for 5 min at RT and then detected on
Kodak ﬁlm. Antibodies used were against calmodulin binding protein
(CBP) (Abcam,MA), dengue virus (Millipore, MA),West Nile envelope
protein (L2, CT) and the HA tag (Santa Cruz Biotechnology, CA).
Immunoﬂuorescence assays
For immunoﬂuorescence assays, the C6/36 cells were ﬁxed in 4%
paraformaldehyde for 15 min at RT and then permeablilized with 0.1%
Triton-X 100 for 1 min at RT before incubation with appropriate
antibody. Antibodies used were against calmodulin binding protein
(CBP) (Abcam, MA), dengue virus (Millipore, MA), West Nile
envelope protein (L2, CT) and the HA tag (Santa Cruz Biotechnology,
CA). Cells were blocked in 1% BSA (Fisher Scientiﬁc, PA) in PBS (-) for
20 min at room temperature and were then incubated with primary
antibody diluted in 1% BSA 1/250 for 20 min at RT. Cells were washed,
incubated with labeled secondary antibody diluted in 1% BSA 1/500
for 20 min at RT and analyzed by ﬂuorescent microscopy. A DAPI stain
(Sigma-Aldrich, MO) was also incubated with the cells for 1 min at RT
to illustrate the location of nucleus in the mosquito cell.
Supplementarymaterials related to this article can be found online
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